Author:
Carrascosa José Manuel,Echarri Ana,Gavín Sebastián Olga,García de la Peña Paloma,Martínez Pérez Oscar,Ramirez Susan,Valderrama Mónica,Montoro Álvarez María
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Kuek A, Hazleman BL, Ostör AJ. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J. 2007;83(978):251–60.
2. David T, Ling SF, Barton A. Genetics of immune-mediated inflammatory diseases. Clin Exp Immunol. 2018;193(1):3–12.
3. El-Gabalawy H, Guenther LC, Bernstein CN. Epidemiology of immune-mediated inflammatory diseases: incidence, prevalence, natural history, and comorbidities. J Rheumatol Suppl. 2010;85:2–10.
4. Puig L, Ruiz de Morales JG, Dauden E, et al. La prevalencia de diez enfermedades inflamatorias inmunomediadas (IMID) en España Prevalence of ten Immune-mediated inflammatory diseases (IMID) in Spain. Rev Esp Salud Publica. 2019;93:e201903013.
5. Huang J, Fu X, Chen X, Li Z, Huang Y, Liang C. Promising therapeutic targets for treatment of rheumatoid arthritis. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.686155.